How Can We Increase the Utilization of Evidence-Based Medication After Myocardial Infarction?

被引：1
作者：
Cavender, Matthew A. [1 ]
Smith, Sidney C. [1 ]
机构：
[1] Univ N Carolina, 160 Dent Cir, Chapel Hill, NC 27599 USA
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 11期
关键词：
OUTCOMES;
D O I：
10.1001/jamanetworkopen.2024.47075
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 7 条
[1]   Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54 [J].
Bhatt, Deepak L. ;
Bonaca, Marc P. ;
Bansilal, Sameer ;
Angiolillo, Dominick J. ;
Cohen, Marc ;
Storey, Robert F. ;
Im, Kyungah ;
Murphy, Sabina A. ;
Held, Peter ;
Braunwald, Eugene ;
Sabatine, Marc S. ;
Steg, Ph. Gabriel .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (23) :2732-2740
[2]   Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry [J].
Cavender, Matthew A. ;
Steg, Ph Gabriel ;
Smith, Sidney C., Jr. ;
Eagle, Kim ;
Ohman, E. Magnus ;
Goto, Shinya ;
Kuder, Julia ;
Im, Kyungah ;
Wilson, Peter W. F. ;
Bhatt, Deepak L. .
CIRCULATION, 2015, 132 (10) :923-931
[3]   Prescription Fills Among Patients With Type 2 Diabetes After Hospitalization for Acute Coronary Syndrome [J].
Kelsey, Michelle D. ;
Ford, Cassie ;
Oakes, Megan ;
Soneji, Samir ;
Bosworth, Hayden B. ;
Pagidipati, Neha J. .
JAMA NETWORK OPEN, 2024, 7 (11) :e2447102
[4]   Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [J].
Nelson, Adam J. ;
O'Brien, Emily C. ;
Kaltenbach, Lisa A. ;
Green, Jennifer B. ;
Lopes, Renato D. ;
Morse, Caryn G. ;
Al-Khalidi, Hussein R. ;
Aroda, Vanita R. ;
Cavender, Matthew A. ;
Gaynor, Tanya ;
Kirk, Julienne K. ;
Lingvay, Ildiko ;
Magwire, Melissa L. ;
McGuire, Darren K. ;
Pak, Jonathan ;
Pop-Busui, Rodica ;
Richardson, Caroline R. ;
Senyucel, Cagri ;
Kelsey, Michelle D. ;
Pagidipati, Neha J. ;
Granger, Christopher B. .
JAMA NETWORK OPEN, 2022, 5 (02)
[5]   Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes A Randomized Clinical Trial [J].
Pagidipati, Neha J. ;
Nelson, Adam J. ;
Kaltenbach, Lisa A. ;
Leyva, Monica ;
McGuire, Darren K. ;
Pop-Busui, Rodica ;
Cavender, Matthew A. ;
Aroda, Vanita R. ;
Magwire, Melissa L. ;
Richardson, Caroline R. ;
Lingvay, Ildiko ;
Kirk, Julienne K. ;
Al-Khalidi, Hussein R. ;
Webb, Laura ;
Gaynor, Tanya ;
Pak, Jonathan ;
Senyucel, Cagri ;
Lopes, Renato D. ;
Green, Jennifer B. ;
Granger, Christopher B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (15) :1261-1270
[6]   Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial [J].
Sabatine, Marc S. ;
Leiter, Lawrence A. ;
Wiviott, Stephen D. ;
Giugliano, Robert P. ;
Deedwania, Prakash ;
De Ferrari, Gaetano M. ;
Murphy, Sabina A. ;
Kuder, Julia F. ;
Gouni-Berthold, Ioanna ;
Lewis, Basil S. ;
Handelsman, Yehuda ;
Pineda, Armando Lira ;
Honarpour, Narimon ;
Keech, Anthony C. ;
Sever, Peter S. ;
Pedersen, Terje R. .
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (12) :941-950
[7]   Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].
Fischereder, Michael ;
Schoenermarck, Ulf .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11) :1092-1093
1